Biotech
Navigating the Markets: Transparency in Trading
Written by Mark Messier at BioRunUp.com — In 2009 the markets were roaring back after a steep decline. You could practically through a dart at a dartboard full of stock tickers, and pick a winner. Times have changed. The market has slowed, if not reversed, and it is much more difficult to pick winners, or [...]
Continue reading...Trading FDA, Clinical Trial Binary Events: $ASTM $CAPS $FRX $MRK
6 July 2010 – 8:54 am PDT
Comments Off
Below are some Regulatory Catalyst Index updates for FDA and clinical trial related news from today… 1.) Aastrom Biosciences (NASDAQ:ASTM) ($1.43, $40 million market cap) Autologous (patient-derived) vascular repair cells (VRCs) are being evaluated in an ongoing Phase 2b clinical trial for the treatment of critical limb ischemia (CLI). ASTM announced treatment of the final [...]
Continue reading...Trading FDA, Clinical Trial Binary Events: $HSP $JAV $VCRT.OB
2 July 2010 – 4:18 pm PDT
Comments Off
Below are summaries of the most recent articles written by Mark Messier at www.BioRunUp.com – please visit the site to read the full articles, in addition to many other free tools and strategies related to binary event investing. Run-Up Method? How About the “Run-Down” Method? Posted: Fri, 02 Jul 2010 03:42:07 +0000 By looking at [...]
Continue reading...Trading FDA, Clinical Trial Binary Events at BioRunUp.com: $SOMX $DNDN $ALKS
1 July 2010 – 3:40 pm PDT
Comments Off
Below are summaries of the most recent articles written by Mark Messier at www.BioRunUp.com – please visit the site to read the full articles, in addition to many other free tools and strategies related to binary event investing. Somaxon Pharma (NASDAQ:SOMX) – An Example of Why NOT to Hold After FDA Approval Posted: Thu, 01 [...]
Continue reading...Trading FDA, Clinical Trial Binary Events with Revised Bio Run-Up Strategy: $AMRN $CADX $EXAS
30 June 2010 – 5:28 pm PDT
Comments Off
Written by Tyler Trimbath. When playing a bio run-up stock in a down market, it may be useful to adjust your strategy… Several weeks ago I wrote an article on the bio run-up strategy explaining how a first-time investor should develop a strategy and stick with it. At this point we are in a market [...]
Continue reading...Trading FDA, Clinical Trial Binary Events at BioRunUp.com: $ISA.TO $ALKS $JAZZ $VRX $OREX
28 June 2010 – 2:54 pm PDT
Comments Off
Below are summaries of the most recent articles written by Mark Messier at www.BioRunUp.com – please visit the site to read the full articles, in addition to many other free tools and strategies related to binary event investing. This Week’s Watchlist 6/28/10 Posted: Mon, 28 Jun 2010 04:30:20 +0000 ISA.TO – Isotechnika has some explaining [...]
Continue reading...Trading FDA, Clinical Trial Binary Events: Why Amarin (NASDAQ:AMRN) is My Top Buy
25 June 2010 – 3:10 pm PDT
Amarin Corp. (NASDAQ:AMRN) is developing AMR101 (Ethyl-EPA) as a prescription-grade omega-3 fatty acid that has been marketed in Japan for over 10 years as EPADEL by Mochida Pharma. Ethyl-EPA is differentiated from Glaxo’s (NYSE:GSK) $1 billion dollar product LOVAZA (omega-3-acid ethyl esters) in the following key areas: - no fishy smell / taste or GI [...]
Continue reading...Trading FDA, Clinical Trial Binary Events at BioRunUp.com: $ISTA $ARNA $VVUS $ISA.TO
23 June 2010 – 5:18 am PDT
Comments Off
Below are summaries of the most recent articles written by Mark Messier at www.BioRunUp.com – please visit the site to read the full articles, in addition to many other free tools and strategies related to binary event investing. ISTA – sNDA for XiDay with a PDUFA Date of 10/16/10 ISTA (ISTA Pharmaceuticals) is another company [...]
Continue reading...FDA, Clinical Trial Extreme Trades: $ASTM $CBRX $SPEX
22 June 2010 – 4:28 pm PDT
Comments Off
Below is a selection of companies with stock prices below $5 per share, market caps below $100 million, and upcoming binary events in the form of FDA news / decisions or clinical trial results. Following the announcement last week that the virtual / social investing website MarketGuru.com will be closing by the end of June, [...]
Continue reading...Trading FDA, Clinical Trial Binary Events: Real Money Portfolio Tracking
20 June 2010 – 4:49 pm PDT
Comments Off
Following the announcement last week that the virtual / social investing website MarketGuru.com will be closing by the end of June, I have synced my TD Ameritrade online brokerage account with a new free service offered by wikinvest.com that includes a variety of portfolio tracking and monitoring tools. There is currently no widget available to share [...]
Continue reading...
7 July 2010 – 5:45 am PDT
Comments Off